Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMLA and Oral Glucose for Procedural Pain in Preterm Neonates
NCT00808054Phase 4Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in procedural pain comparing Glucose and EMLA, Oral placebo and EMLA and Glucose and placebo (3 arms). Primary endpoints: Neonatal Infant Pain Scale at 1 week, Heart Rate at 1 week and 3 more. Started Nov 2008; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT00808054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808054.